Loading provider…
Loading provider…
Infectious Disease Physician in Los Angeles, CA
NPI: 1265655203Primary Practice Location
RONALD REAGAN UCLA MEDICAL CENTER
757 Westwood Plz, Los Angeles, CA
Primary Employer
Resnick Neuropsychiatric Hospital at UCLA
uclahealth.org
HQ Phone
Get MD Drew's Phone Numberphone_androidMobile
Get MD Drew's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
1977 - 2026
CA State Medical License

American Board of Internal Medicine
Internal Medicine
UCLA David Geffen School of Medicine/UCLA Medical Center
Fellowship • Infectious Disease
1976 - 1977
Residency • Internal Medicine
1975 - 1976
University of Missouri-Columbia
Internship • Internal Medicine
1972 - 1973
University of Missouri School of Medicine
medicine.missouri.edu
Medical School
Until 1972
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99291Critical care delivery critically ill or injured patient, first 30-74 minutes | 18 | 292 |
| 2 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 13 | 45 |
| 3 | 99223Initial hospital inpatient care, typically 70 minutes per day | 12 | 12 |
Authors: Robin Avery, Genovefa Papanicolaou
Journal: J Infect Dis
'Utilization of whole genome sequencing for resolution of discrepant Mycobacterium
Authors: Susan Realegeno, Oladunni Adeyiga, Omer E. Beaird, Omai B. Garner, Shangxin
Publication Date: 2021-01
Intravenous immune globulin for prevention of cytomegalovirus infection and
Authors: Drew J. Winston, Winston G. Ho, Cheng-Hsien Lin, Kathy Bartoni, Miriam D.
Publication Date: 1987-01
Lead Sponsor: Chimerix
Intervention / Treatment: DRUG: Brincidofovir
Lead Sponsor: Chimerix
Intervention / Treatment: DRUG: Standard of Care, DRUG: Brincidofovir
Lead Sponsor: Chimerix
Intervention / Treatment: DRUG: CMX001